Why does tirzepatide degrade and expire?
Tirzepatide is a 39-amino-acid peptide. Like all peptides, it is susceptible to degradation under conditions that disrupt the molecular structure — elevated temperature, freeze-thaw cycles, prolonged light exposure, and physical agitation all accelerate breakdown. When a peptide degrades, the therapeutic molecule fragments into smaller pieces that do not bind their target receptors the same way, potentially meaning the medication delivers less effect per dose than expected — or introduces degradation products whose biological activity is unknown.
This is not a theoretical concern. It is the reason pharmaceutical companies invest significantly in formulation science — finding excipients, pH ranges, and packaging that keep the active molecule intact from manufacturing to the point of injection.
How does branded tirzepatide expire and how should you store it?
Branded Mounjaro and Zepbound autoinjector pens carry a manufacturer-assigned expiration date printed on the label. Eli Lilly has conducted stability testing to determine how long the product retains potency within their formulation.
Standard storage requirements for branded tirzepatide pens:
- Before first use: Store refrigerated at 36–46°F (2–8°C). Do not freeze.
- After removal from refrigerator: Mounjaro and Zepbound pens may be stored at room temperature below 86°F (30°C) for a defined period — check the current prescribing information for the specific permitted duration, as this can update.
- Expiration date: Do not use after the date printed on the label regardless of appearance.
- Light protection: Keep in the original carton; do not expose to direct sunlight.
What is the beyond-use date for compounded tirzepatide?
Compounded tirzepatide from a 503A pharmacy operates under a different framework than branded products. Compounded tirzepatide is not FDA-approved; it is not the same as Mounjaro or Zepbound, and no efficacy or safety equivalence to those branded products should be assumed. Instead of a manufacturer expiration date backed by multi-year stability studies, compounded preparations carry a beyond-use date (BUD) assigned by the compounding pharmacy based on USP guidelines for sterile preparations (USP <797>) and available stability data for the specific formulation.
For a reconstituted compounded tirzepatide solution:
- Typical BUD: 28 days refrigerated is common for compounded peptide solutions, though your specific pharmacy may assign a shorter or longer window depending on their formulation and stability testing. The BUD on your pharmacy label is the authoritative date — not a general guideline.
- Label it: When you reconstitute a lyophilized vial, write the date and time of reconstitution on the label. Count forward to the BUD your pharmacy specifies.
- Lyophilized vs. liquid: Lyophilized (freeze-dried) powder before reconstitution generally has a longer shelf life than reconstituted liquid. Your pharmacy will specify both the pre- and post-reconstitution windows on the label.
The beyond-use date printed on your pharmacy label — not a generic online figure — is the authoritative deadline for a reconstituted tirzepatide vial.
What happens if a vial is accidentally frozen?
Freezing a reconstituted tirzepatide solution is a common accidental error. Refrigerators vary in temperature, and vials stored near the back of a drawer or next to a cooling element can freeze without the patient realizing it.
Freezing a peptide solution can cause ice crystal formation that damages the molecular structure. Freeze-thaw cycles are particularly damaging to peptide integrity. If a compounded tirzepatide vial has been accidentally frozen:
- Do not inject the thawed solution
- Contact your pharmacy or clinician before using it
- A reputable pharmacy can advise on whether the specific formulation may tolerate a single freeze-thaw event — some cannot
- When uncertain, the safer choice is to discard and replace
What should tirzepatide look like — and when should you discard a vial?
Before drawing any dose from a tirzepatide vial, hold it up to light and inspect the solution:
- Color: Should be clear to pale yellow (formulation-dependent). Unusual discoloration is a warning sign.
- Clarity: Should be transparent, not cloudy or turbid. Cloudiness can indicate precipitation, contamination, or degradation.
- Particulates: No visible particles, fibers, or floating material. Any particulates mean do not inject — call your pharmacy.
- Smell: If a vial has an unexpected odor when opened, this is also a red flag.
A solution can look fine and still be degraded if the degradation is molecular rather than visible — which is why storage conditions and the BUD matter even when a vial looks acceptable. But any visible abnormality is an absolute reason to stop.
How should you travel with tirzepatide?
Temperature control during travel is an underappreciated issue for patients on injectable therapies. General guidance:
- Short trips (under 24 hours): Use an insulated case with a refrigerant pack (not direct ice) to keep the vial cool without freezing it.
- Air travel: Carry in your carry-on, never in checked luggage (cargo holds can freeze). Have your prescription documentation available.
- Hot climates: Do not leave a tirzepatide vial in a hot car or exposed to direct sun. Heat accelerates degradation faster than most patients assume.
- Longer trips: Consult your clinician about timing injections around travel so that you minimize in-transit storage requirements.
Frequently asked questions
Does tirzepatide expire?
Yes. Both branded tirzepatide (Mounjaro, Zepbound) and compounded tirzepatide have expiration or beyond-use dates that should not be exceeded. Using expired tirzepatide may mean the medication has degraded and is less effective or potentially unsafe. Never inject medication past its expiration or beyond-use date.
What is a beyond-use date (BUD) for compounded tirzepatide?
A beyond-use date is the date after which a compounded preparation should not be used, as determined by the compounding pharmacy based on stability data and USP guidelines. For reconstituted compounded tirzepatide, the BUD is typically 28 days when stored refrigerated. Your pharmacy will specify this date — do not use the vial after it.
How should compounded tirzepatide be stored?
Refrigerate at 36–46°F (2–8°C). Keep away from light. Do not freeze. Do not leave at room temperature for extended periods. A reconstituted vial left unrefrigerated for more than a few hours should be discarded. Specific storage guidance may vary by pharmacy formulation — follow your pharmacy's instructions.
What happens if tirzepatide is not stored properly?
Improper storage — freezing, heat exposure, or extended time at room temperature — can degrade the peptide. A degraded solution may be less potent or may contain breakdown products with unknown effects. If a solution appears cloudy, discolored, or has visible particulates after storage, discard it and contact your pharmacy.
Can I use a tirzepatide vial that was accidentally left out overnight?
This depends on the temperature and duration of exposure. Branded tirzepatide products (Mounjaro, Zepbound) have manufacturer data supporting limited room-temperature storage periods. For compounded tirzepatide, contact your pharmacy for specific guidance — do not guess. When in doubt, discard the vial; the risk of injecting a degraded preparation outweighs the cost of a replacement.
What does tirzepatide look like if it has gone bad?
A properly stored, in-date tirzepatide solution should be clear and colorless to pale yellow (depending on formulation). Signs of potential degradation or contamination include: cloudiness, visible particles or floaters, unusual color, or an off smell when the vial is opened. If you observe any of these, do not inject — contact your pharmacy.
Why does pharmacy quality matter?
The stability and beyond-use dating of a compounded tirzepatide preparation depends heavily on the quality of the compounding pharmacy. A 503A pharmacy operating under USP <797> standards uses controlled conditions — cleanroom environments, validated testing, and documented quality systems — to maximize the safety and stability of each batch.
Gray-market tirzepatide from unregulated vendors carries none of those assurances. There is no way to know the actual concentration, purity, or sterility of an unlicensed preparation — and no recourse if something goes wrong.
PepScribe works exclusively with US-licensed 503A compounding pharmacies. No hidden overseas supply chain. If you’re evaluating a tirzepatide program, the place to start is a short intake assessment with a licensed clinician. More on the program is on our tirzepatide overview page.